Musculoskeletal and connective tissue disorders – page 43

Study on the Effects of Fipaxalparant in Patients with Diffuse Cutaneous Systemic Sclerosis

Study on the Effects of Fipaxalparant in Patients with Diffuse Cutaneous Systemic Sclerosis

Study of Obexelimab Treatment for Adults with Systemic Lupus Erythematosus (SLE)

Study of Obexelimab Treatment for Adults with Systemic Lupus Erythematosus (SLE)

Study on the Effectiveness and Safety of LY06006 and Denosumab for Postmenopausal Women with Osteoporosis

Study on the Safety of RTX-GRT7039 and Ropivacaine Hydrochloride Injections for Patients with Moderate to Severe Knee Osteoarthritis Pain

Study on the Safety of RTX-GRT7039 and Ropivacaine Hydrochloride Injections for Patients with Moderate to Severe Knee Osteoarthritis Pain

Study on the Effects of AP1189 and Methotrexate for Patients with Early Rheumatoid Arthritis and Active Inflammation

Study on the Effects of AP1189 and Methotrexate for Patients with Early Rheumatoid Arthritis and Active Inflammation

Study of Risankizumab vs. Placebo for Patients with Active Psoriatic Arthritis and Inadequate Response to DMARD Therapy

Study of Risankizumab vs. Placebo for Patients with Active Psoriatic Arthritis and Inadequate Response to DMARD Therapy

Study on the Effects of Human Normal Immunoglobulin in Adults with Dermatomyositis

Study on the Effects of Human Normal Immunoglobulin in Adults with Dermatomyositis

Study on the Effectiveness and Safety of Abatacept Biosimilar (DRL_AB) and Methotrexate for Patients with Moderate to Severe Rheumatoid Arthritis

Study on the Effectiveness and Safety of Abatacept Biosimilar (DRL_AB) and Methotrexate for Patients with Moderate to Severe Rheumatoid Arthritis

Study on Guselkumab for Treating Psoriatic Arthritis in Patients New to Biologic Therapy

Study on Guselkumab for Treating Psoriatic Arthritis in Patients New to Biologic Therapy

Study of Anifrolumab for Adults with Moderate-to-Severe Systemic Lupus Erythematosus

Study of Anifrolumab for Adults with Moderate-to-Severe Systemic Lupus Erythematosus

Study on Tildrakizumab for Patients with Active Psoriatic Arthritis Who Have Previously Used Anti-TNF Therapy

Study on Tildrakizumab for Patients with Active Psoriatic Arthritis Who Have Previously Used Anti-TNF Therapy

Study on the Effects of Fipaxalparant in Patients with Diffuse Cutaneous Systemic Sclerosis

Study on the Effects of Fipaxalparant in Patients with Diffuse Cutaneous Systemic Sclerosis